Records containing: Hyperphosphatemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-07-25A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-center, Withdrawal Study Comparing MCI-196 v.s Placebo Following A 12-Week Dose Titration Period With MCI-196 in Stage V Subjects on Dialysis With Hyperphosphatemia
-
CLINICAL_TRIALS study record update · 2014-07-16ASP1585 Phase 3 Randomized Double Blind Placebo-controlled Study in Chronic Kidney Disease (CKD) Patients With Hyperphosphatemia Not on Dialysis
-
CLINICAL_TRIALS study record update · 2014-06-23Bioequivalence Study of BAY77-1931 Granule - Randomized, Non-blind, Two-way, Crossover Study to Establish the Bioequivalence Between BAY77-1931 Granule 500 mg and Fosrenol Chewable Tablet 500 mg in Japanese Healthy Male Adult Subjects
-
CLINICAL_TRIALS study record update · 2014-06-20Open Label, Non-controlled Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone in Patients With Hyperphosphatemia Receiving Dialysis
-
CLINICAL_TRIALS study record update · 2014-05-12A Phase III, Multi-center, Open Label, Flexible Dose, Long Term Safety Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-05-15ClinicalTrials.gov study NCT01854437
-
CLINICAL_TRIALS study record update · 2013-01-23A Long-term, Open Label Extension, Non-controlled Study to Assess the Efficacy and Safety of BAY 77-1931 (Lanthanum Carbonate) for Hyperphosphatemia in Patients Undergoing Hemodialysis
-
CLINICAL_TRIALS study record update · 2012-09-26Study of the Effect of Treatment With Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure
-
CLINICAL_TRIALS study record update · 2012-06-08Phase III Double-blind Comparative Study of BAY 77 1931 (Lanthanum Carbonate) With a Calcium Carbonate in Patients With Hyperphosphatemia Undergoing Hemodialysis
-
CLINICAL_TRIALS study record update · 2012-06-01ClinicalTrials.gov study NCT01039428
-
CLINICAL_TRIALS study record update · 2012-01-18Dose Finding Study of Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
-
CLINICAL_TRIALS study record update · 2011-11-15A Single Blind Pharmacodynamic Study to Assess the Phosphate Binding Characteristics of K2CG Chewing Gum
-
CLINICAL_TRIALS study record update · 2011-11-15A Phase III, Double-Blind, Multi-Centre, Randomised, Parallel Group Design, Placebo-Controlled, Flexible Dose Study of MCI-196 in Combination With a Ca-Based Phosphate Binder in CKD Stage V Subjects on Dialysis With Hyperphosphatemia.
-
CLINICAL_TRIALS study record update · 2011-06-15A Long-term, Observational Study to Monitor Mortality, Bone-related Adverse Events and the Safety of Subjects Who Were Recruited Into Study SPD405-309
-
CLINICAL_TRIALS study record update · 2011-04-18ClinicalTrials.gov study NCT01329497
-
CLINICAL_TRIALS study record update · 2011-03-22A Phase 2, Randomized, Double-blind-placebo-controlled and Open-label-Sevelamer Hydrochloride-controlled, Dose-ranging Study for ASP1585 in Patients With Chronic Kidney Disease(CKD) and Hyperphosphatemia on Hemodialysis
-
CLINICAL_TRIALS study record update · 2011-01-07A Double Blind, Randomized, Placebo Controlled Trial to Evaluate the Efficacy and Safety of FOSTRAP Chewing Gum in Patients With Chronic Kidney Disease and Hyperphosphatemia.
-
CLINICAL_TRIALS study record update · 2010-11-22The Influence of Dietary Phosphorus Education Program on Nutritional Status and Serum Phosphate Level Among Hemodialysis Patient
-
CLINICAL_TRIALS study record update · 2009-04-01Phosphorus Improvement Pilot Study
-
CLINICAL_TRIALS study record update · 2009-02-09Randomized, Controlled, 3-Arm, Open Label, Cross-Over Bioequivalence Study Comparing Liquid PhosLo vs. PhosLo Gelcaps Using Calcium Citrate as a Positive Control in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2009-02-03An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients
-
CLINICAL_TRIALS study record update · 2009-01-16The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients
-
CLINICAL_TRIALS study record update · 2008-01-08EPIC (Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease): A Prospective, Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Parallel Arm, Study of PhosLo on Phosphorus Levels in Subjects With Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2007-11-08Study of Klotho Gene Polymorphisms in the Regulation of Serum Phosphate Levels in Hemodialysis Patients
-
CLINICAL_TRIALS study record update · 2007-07-30The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients